Funding for this research was provided by:
Merck Sharp and Dohme (EuroRotaNet)
Received: 18 December 2018
Accepted: 3 October 2019
First Online: 27 November 2019
Ethics approval and consent to participate
: This study was approved by the Clinical Research Ethics Committee of the Hospital Clínico Universitario of Valencia and the Juvenile Prosecutor’s Office of Valencia, which conformed to the ethical guidelines of the Helsinki Declaration. Written informed consent to participate was obtained from the parents or legal guardians of the children included in the study.
: Not applicable.
: JB has received research grant support from GlaxoSmithKline Biologicals and Sanofi Pasteur MSD for work on rotavirus. The other authors declare no competing interests.